Arlene Weintraub is a science journalist and author with 20 years of experience writing about healthcare, pharmaceuticals and biotechnology.
Selling The Promise Of Youth - Businessweek
Biotech: Generics Win a Round - Businessweek
The White House has endorsed a seven-year limit to data exclusivity. One big winner: Teva Pharmaceuticals
What the Doctors Aren't Disclosing - Businessweek
Genentech's Medicine Man - Businessweek
Medicine In Conflict - Businessweek
Ad Vantage: The Williams Sisters - Businessweek
Inside Drugmakers' War on Fat
A huge jackpot awaits the company that devises an effective fix for obesity
Like hundreds of other executives whose companies are trying to develop blockbuster weight-loss drugs, Amylin Pharmaceutical...
Aging-in-Place Made Easy: Staying Healthy and Safe, at Home ...
Repairing The Engines Of Life - Businessweek
A "Body Blow" To Stem Cell Research - Businessweek
Amgen's Bone-Loss Drug Faces Marketing Hurdles - Businessweek
Amgen is likely to receive FDA approval for denosumab, its newbiologic bone-loss drug, but it may be a hard sell against cheaper generics
Ask Your Doctor If This Ad Is Right for You - Businessweek
The drug industry is spending billions on TV ads, but they may be scaring consumers away
A Thousand-Year Plan for Nuclear Waste - Businessweek
Can Roche Leave Genentech Alone? - Businessweek
Now that it has acquired the biotech superstar, success will depend on keeping some distance
Doctors Under the Influence? - Businessweek